THC
17.4–19.8%
CBD
0.3%
Calizahr, the Chimera Seeds hybrid, tests 17.4-19.8% THC and is documented for use with pain and stress.
No effect, terpene or flavor data specific to Calizahr has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
Explore More
THC in this profile
19.8% THC
About Calizahr
Chimera Seeds' version of this hybrid tests between 17.4 and 19.8 percent THC, a solidly mid-to-upper range that keeps it out of extreme territory in either direction. The two medical uses recorded for it, pain and stress, are the only qualitative notes attached to the listing, no effects, flavors, or terpenes have been logged, so there's nothing to say about how it tastes or what specific sensations it produces beyond those two applications. Grow details are similarly absent, with no flowering window, height, or yield on file. What remains is a fairly narrow but useful profile: a known potency bracket and two documented reasons people reach for this particular cut, even if the fuller sensory picture hasn't been written down yet.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Calizahr
Is Calizahr an Indica, Sativa, or Hybrid?
Calizahr is classified as a hybrid cannabis strain.
What cannabinoid content is reported for Calizahr?
Calizahr: 19.8% THC and 0.3% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.